Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/19/2021 10/20/2021 10/21/2021 10/22/2021 10/25/2021 Date
333.61(c) 333.01(c) 339.57(c) 326.54(c) 349.56 Last
8 561 130 4 983 222 5 597 599 7 780 241 9 772 171 Volume
-0.37% -0.18% +1.97% -3.84% +7.05% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash position 2021 13 559 M - -
P/E ratio 2021 11,7x
Yield 2021 -
Sales 2022 20 718 M - -
Net income 2022 10 722 M - -
Net cash position 2022 26 152 M - -
P/E ratio 2022 14,1x
Yield 2022 -
Capitalization 141 B 141 B -
EV / Sales 2021 6,26x
EV / Sales 2022 5,55x
Nbr of Employees 1 300
Free-Float 90,3%
More Financials
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and... 
More about the company
Ratings of Moderna, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MODERNA, INC.
05:58pMODERNA : U.S. administers 414.3 mln doses of COVID-19 vaccines - CDC
RE
05:28pMODERNA : U.S. CDC Says Delivered 503,418,475 Doses Of Covid-19 Vaccine As Of Oct 25
RE
05:05pMODERNA : European Medicines Agency Panel Recommends Booster Shots for Moderna's COVID-19 ..
MT
04:53pMODERNA : Announces European Medicines Agency's Committee for Medicinal Products for Human..
BU
04:25pTesla, Moderna rise; Kimberly-Clark, Restaurant Brands fall
AQ
01:47pMODERNA : EU drug regulator OKs booster doses of Moderna's COVID shot
AQ
01:14pMODERNA : EMA backs use of Moderna's COVID-19 booster vaccine
RE
01:09pPFIZER : Moderna says studies show COVID-19 vaccine safe, effective in children 6-11
AQ
01:06pMODERNA : EMA backs use of Moderna's COVID-19 booster vaccine
RE
11:31aPFIZER : Moderna says its low-dose COVID shot works for kids 6 to 11
AQ
11:28aModerna Shares Higher After Interim Data for Covid-19 Vaccine in Children
DJ
10:43aPfizer, Moderna and J&J Booster Shots Now Available at Walmart and Sam's Club Pharmacie..
AQ
10:43aMODERNA : Hy-Vee Now Offering Free Moderna and Janssen (J&J) COVID-19 Booster Vaccines to ..
AQ
10:43aMODERNA : Walgreens Now Offering Moderna and Johnson & Johnson COVID-19 Vaccine Booster Sh..
AQ
09:33aINSIDER SELL : Moderna
MT
More news
News in other languages on MODERNA, INC.
05:18pWALL STREET : 2 records absolu, Tesla au-delà des 1.000Mds$
05:05pLe panel de l'Agence européenne des médicaments recommande des injections de rappel pou..
04:24pMÄRKTE USA/Neue Rekorde - Tesla-Marktkapitalisierung über 1 Billion USD
02:49pUSA-Reisen ab November möglich nach Impfung mit anerkannten Stoffen
02:44pCORONA-BLOG/EMA lässt Moderna-Auffrischungsimpfung für über 18-Jährige zu
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Stock Trading Strategies
MODERNA, INC. - 2020
The beginning of the move
BUY
More Stock Trading Analysis
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 349,56 $
Average target price 295,79 $
Spread / Average Target -15,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.234.60%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.58%49 076
SEAGEN INC.0.22%31 189
CELLTRION, INC.-39.69%25 455
ALNYLAM PHARMACEUTICALS, INC.53.63%23 604